ALEC · Alector, Inc.
$1.52
+0.00 (+0.00%)
At close · Jul 29
Market Cap
$168.76M
Shares
111.03M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$21.05M
-79.1%
FY2025
Net Income
-$142.93M
-20.1%
FY2025
Operating Margin
-741.3%
-597.1pp
FY2025
Diluted EPS
-$1.39
-13%
FY2025
Operating Cash Flow
-$184.03M
+20%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $18.42M | $21.05M | $100.56M | $97.1M | $133.6M | $207.09M | $21.1M | $21.22M | $27.68M | $3.74M | |
| $107.28M | $123.07M | $185.94M | $192.12M | $210.42M | $189.41M | $156.87M | $100.53M | $73.03M | $29.91M | |
| $47.37M | $53.99M | $59.62M | $56.69M | $61.03M | $55.04M | $59.4M | $35.1M | $11.93M | $6.5M | |
| — | $5.72M | $5.41M | $5.73M | $5.71M | $6.33M | $5.87M | $3.78M | $1.02M | $680K | |
| -$300K | $2.3M | $3.9M | $1.7M | — | — | — | — | — | — | |
| $154.65M | $177.05M | $245.56M | $248.8M | $271.45M | $244.45M | $216.27M | $135.62M | $84.97M | $36.41M | |
| -$136.23M | -$156.01M | -$145M | -$151.74M | -$137.83M | -$37.36M | -$195.17M | -$114.4M | -$57.29M | -$32.68M | |
| — | -741.3% | -144.19% | -156.27% | -103.17% | -18.04% | -925.08% | -539.16% | -206.99% | -874.94% | |
| — | -$150.29M | -$139.59M | -$146.02M | -$132.12M | -$31.03M | -$189.3M | -$110.63M | -$56.27M | -$32M | |
| $11.01M | $13.25M | $26.08M | $26.56M | $7.78M | $1.03M | $4.95M | $9.02M | $5.04M | $199K | |
| -$125.22M | -$142.76M | -$118.92M | -$125.1M | -$130.1M | — | — | — | — | — | |
| $168K | $168K | $128K | $5.21M | $3.25M | $0 | $0 | $0 | — | — | |
| -$125.39M | -$142.93M | -$119.05M | -$130.39M | -$133.31M | -$36.33M | -$190.23M | -$105.39M | -$52.25M | -$32.48M | |
| — | -679.16% | -118.39% | -134.29% | -99.78% | -17.54% | -901.64% | -496.65% | -188.78% | -869.61% | |
| -$125.68M | -$143.02M | -$118.97M | -$125.63M | -$136.94M | -$37.89M | -$189.76M | -$105.2M | -$52.29M | -$32.48M | |
| USD/shares | — | -$1.39 | -$1.23 | -$1.56 | -$1.62 | -$0.45 | -$2.45 | — | — | — |
| USD/shares | — | -$1.39 | -$1.23 | -$1.56 | -$1.62 | -$0.45 | -$2.45 | — | — | — |
| shares | — | 103M | 96.59M | 83.73M | 82.47M | 80.42M | 77.76M | 61.73M | 11.3M | 9.14M |
| shares | — | 103M | 96.59M | 83.73M | 82.47M | 80.42M | 77.76M | 61.73M | 11.3M | 9.14M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.80×
EV/EBIT
—
Peer median 26.45×
P/E (TTM)
—
Peer median 4.65×
Peer medians compare against the 300 similar-size Biotechnology companies (of 522 listed).
Key facts
CIK
1653087
CUSIP
014442107
13F (30d)
20 filings
20 filers
Visit website
Investor relations